(GINA) 2006 - Global Initiative for Asthma

BIBLIOGRAFIA
1. Levy ML, Fletcher M, Price DB, Hausen T, Halbert RJ, Yawn P.
International Primary Care Respiratory Group (IPCRG) Guidelines:
diagnosis of respiratory diseases in primary care. Prim Care Respir J
2006;15(1):20-34.
2. Yssel H, Abbal C, Pene J, Bousquet J. The role of IgE in asthma.
Clin Exp Allergy 1998;28 Suppl 5:104-9.
3. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole
presenting manifestation of bronchial asthma. N Engl J Med
1979;300(12):633-7.
4. Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical
manifestations and implications for treatment. Thorax
2002;57(2):178-82.
5. Gibson PG, Dolovich J, Denburg J, Ramsdale EH, Hargreave FE.
Chronic cough: eosinophilic bronchitis without asthma. Lancet
1989;1(8651):1346-8.
6. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V, et
al. Managing cough as a defense mechanism and as a symptom. A
consensus panel report of the American College of Chest
Physicians. Chest 1998;114(2 Suppl Managing):133S-81S.
7. Randolph C. Exercise-induced asthma: update on pathophysiology,
clinical diagnosis, and treatment. Curr Probl Pediatr 1997;27(2):53-
77.
8. Tan WC, Tan CH, Teoh PC. The role of climatic conditions and
histamine release in exercise- induced bronchoconstriction. Ann
Acad Med Singapore 1985;14(3):465-9.
9. Anderson SD. Exercise-induced asthma in children: a marker of
airway inflammation. Med J Aust 2002;177 Suppl:S61-3.
10. Killian KJ, Watson R, Otis J, St Amand TA, O’Byrne PM. Symptom
perception during acute bronchoconstriction. Am J Respir Crit Care
Med 2000;162(2 Pt 1):490-6.
11. Kerstjens HA, Brand PL, de Jong PM, Koeter GH, Postma DS.
Influence of treatment on peak expiratory flow and its relation to
airway hyperresponsiveness and symptoms. The Dutch CNSLD
Study Group. Thorax 1994;49(11):1109-15.
12. Brand PL, Duiverman EJ, Waalkens HJ, van Essen-Zandvliet EE,
Kerrebijn KF. Peak flow variation in childhood asthma: correlation
with symptoms, airways obstruction, and hyperresponsiveness
during long-term treatment with inhaled corticosteroids. Dutch
CNSLD Study Group. Thorax 1999;54(2):103-7.
13. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R,
et al. Interpretative strategies for lung function tests. Eur Respir J
2005;26(5):948-68.
14. Standardization of Spirometry, 1994 Update. American Thoracic
Society. Am J Respir Crit Care Med 1995;152(3):1107-36.
15. Standardized lung function testing. Official statement of the
European Respiratory Society. Eur Respir J Suppl 1993;16:1-100.
16. Sawyer G, Miles J, Lewis S, Fitzharris P, Pearce N, Beasley R.
Classification of asthma severity: should the international guidelines
be changed? Clin Exp Allergy 1998;28(12):1565-70.
17. Eid N, Yandell B, Howell L, Eddy M, Sheikh S. Can peak expiratory
flow predict airflow obstruction in children with asthma? Pediatrics
2000;105(2):354-8.
24 DIAGNOSI E CLASSIFICAZIONE
18. Reddel HK, Marks GB, Jenkins CR. When can personal best peak
flow be determined for asthma action plans? Thorax
2004;59(11):922-4.
19. Reddel HK, Salome CM, Peat JK, Woolcock AJ. Which index of
peak expiratory flow is most useful in the management of stable
asthma? Am J Respir Crit Care Med 1995;151(5):1320-5.
20. Dekker FW, Schrier AC, Sterk PJ, Dijkman JH. Validity of peak
expiratory flow measurement in assessing reversibility of airflow
obstruction. Thorax 1992;47(3):162-6.
21. Boezen HM, Schouten JP, Postma DS, Rijcken B. Distribution of
peak expiratory flow variability by age, gender and smoking habits
in a random population sample aged 20-70 yrs. EurRespir J
1994;7(10):1814-20.
22. Gibson PG, Powell H. Written action plans for asthma: an evidencebased
review of the key components. Thorax 2004;59(2):94-9.
23. Reddel HK, Vincent SD, Civitico J. The need for standardisation of
peak flow charts. Thorax 2005;60(2):164-7.
24. Cockcroft DW. Bronchoprovocation methods: direct challenges. Clin
Rev Allergy Immunol 2003;24(1):19-26.
25. Cockcroft DW, Murdock KY, Berscheid BA, Gore BP. Sensitivity and
specificity of histamine PC20 determination in a random selection of
young college students. J Allergy Clin Immunol 1992;89(1 Pt 1):23-
30.
26. Boulet LP. Asymptomatic airway hyperresponsiveness: a curiosity or
an opportunity to prevent asthma? Am J Respir Crit Care Med
2003;167(3):371-8.
27. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE.
Asymptomatic bronchial hyperresponsiveness in rhinitis. J Allergy
Clin Immunol 1985;75(5):573-7.
28. van Haren EH, Lammers JW, Festen J, Heijerman HG, Groot CA,
van Herwaarden CL. The effects of the inhaled corticosteroid
budesonide on lung function and bronchial hyperresponsiveness in
adult patients with cystic fibrosis. Respir Med 1995;89(3):209-14.
29. Ramsdale EH, Morris MM, Roberts RS, Hargreave FE. Bronchial
responsiveness to methacholine in chronic bronchitis: relationship to
airflow obstruction and cold air responsiveness. Thorax
1984;39(12):912-8.
30. Pizzichini MM, Popov TA, Efthimiadis A, Hussack P, Evans S,
Pizzichini E, et al. Spontaneous and induced sputum to measure
indices of airway inflammation in asthma. Am J Respir Crit Care
Med 1996;154(4 Pt 1):866-9.
31. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide
measurements: recommendations. The European Respiratory
Society Task Force. Eur Respir J 1997;10(7):1683-93.
32. Horvath I, Barnes PJ. Exhaled monoxides in asymptomatic atopic
subjects. Clin Exp Allergy 1999;29(9):1276-80.
33. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D,
Bradding P, et al. Asthma exacerbations and sputum eosinophil
counts: a randomised controlled trial. Lancet 2002;360(9347):1715-
21.
34. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of
exhaled nitric oxide measurements to guide treatment in chronic
asthma. N Engl J Med 2005;352(21):2163-73.